Breakthrough: New Drug NU-9 Could Prevent Alzheimer's Before Memory Loss

• Northwestern University researchers identified a highly toxic protein (Amyloid Beta Oligomer subtype) that damages the brain years before Alzheimer's symptoms appear.
• An experimental drug, NU-9, developed at Northwestern, significantly reduced this toxic protein, inflammation, and brain cell damage in mice.
• NU-9 prevented overactive Astrocytes from causing damage and breaking down brain connections, offering a new therapeutic approach.
• The research suggests Alzheimer's could be prevented or significantly delayed by early intervention with drugs like NU-9, even before memory loss.
• Future plans include early detection via blood tests and potential human clinical trials for NU-9, aiming to control the disease.

Why It Matters: New drug NU-9 shows promise in preventing Alzheimer's before memory loss, offering hope for early intervention.